28th Oct 2008 10:49
|
For Immediate Release |
28 October 2008 |
ALLIANCE PHARMA PLC
("the Company")
Director Share Purchase
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, was informed on 27 October 2008 that Michael Gatenby, the Company's Chairman, purchased 220,000 ordinary shares of 1p each in the Company on 27 October 2008 at a price of 4.0p per share. Mr Gatenby's resultant shareholding is 350,000 ordinary shares, equivalent to 0.22 per cent. of the Company's issued share capital.
For further information:
|
Alliance Pharma plc |
+ 44 (0) 1249 466966 |
|
John Dawson, Chief Executive |
|
|
Richard Wright, Finance Director |
|
|
www.alliancepharma.co.uk |
|
|
Buchanan Communications |
+ 44 (0) 20 7466 5000 |
|
Mark Court / Rebecca Skye Dietrich |
|
|
Numis Securities Limited |
+ 44 (0) 20 7260 1000 |
|
Nominated Adviser: Michael Meade / Brent Nabbs |
|
|
Corporate Broking: David Poutney |
Related Shares:
Alliance Pharma